STATUTORY RULES.
1962. No. 34
REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1961.*
I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1961.
Dated this twelfth day of April, 1962.
DE L’ISLE
Governor-General,
By His Excellency’s Command,
Minister of State for Health.
AMENDMENTS OF THE NATIONAL HEALTH (PHARMACEUTICAL BENEFITS)
REGULATIONS.†
Commencement.
1. These Regulations shall come into operation on the first day of May, 1962.
Standards of composition and purity of pharmaceutical benefits and additives.
2. Regulation 35 of the National Health (Pharmaceutical Benefits) Regulations is amended by adding at the end thereof the following sub-regulation:—
“(6.) Where the letters ‘B.P.C.1954’ appear after the name of the pharmaceutical benefit or the additive, the standards of composition and purity are those constituted by the description of that pharmaceutical benefit and of its ingredients, or of that additive, as the case may be, in the edition of the book called the British Pharmaceutical Codex published by direction of the Council of the Pharmaceutical Society of Great Britain in the year 1954.”.
* Notified in the Commonwealth Gazette on 15th April, 1962.
† Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; and 1961, Nos. 59 and 137.
1699/62.—PRICE 1S 9/6.4.1962.
First, Second, Third, Fourth, and Fifth Schedules.
3. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—
FIRST SCHEDULE.
Regulation 10.
DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS, OR USED IN, PHARMACEUTICAL BENEFITS EXCEPT AS SPECIALLY PROVIDED.
Absorbable Gelatin Sponge. Acetazolamide. Acetomenaphthone. Adrenaline Acid Tartrate. Alcohol. Amethocaine Hydrochloride. Amethocaine Injection. Amodiaquine Hydrochloride. Amphetamine. Amphetamine Sulphate. Amylobarbitone. Amylobarbitone Sodium. Amylobarbitone Sodium Tablets. Antimony Potassium Tartrate. Antimony Sodium Tartrate. Apomorphine Hydrochloride. Azovan Blue. Bacillus Calmette-Guerin Vaccine. Bacitracin. Bemegride. Benzhexol Hydrochloride. Bismuth Oxychloride. Bismuth Oxychloride Injection. Bismuth Sodium Tartrate. Busulphan. Butobarbitone. Calciferol. Caraway. Carbachol. Carbimazole. Carbon Dioxide. Cardamom Fruit. Catgut, sterlized surgical. Cellulose Oxidized. Chlorcyclizine Hydrochloride. Chorionic Gonadotrophin. Chloroquine Phosphate. Chloroquine Sulphate. Chlorothiazide. Chloroxylenol. Chlortetracycline Injection. Cinchocaine Hydrochloride. Cinnamon. Cochineal. Cod Liver Oil. Colchicine. Coriander. Corticotrophin. Cresol. Cyanocobalamin. Cyclobarbitone. Cyclopropane. Dapsone. Dexamphetamine Sulphate. Dextran Injection. | Dextran Sulphate. Dextran Sulphate Injection. Diethylcarbamazine Citrate. Digitalis Leaf. Dimercaprol. Diodone Injection. Dithranol. Emetine and Bismuth Iodide. Emetine Hydrochloride. Ergometrine Maleate. Ether Vinyl. Ethinyloestradiol. Ethisterone. Ethopropazine Hydrochloride. Ethyl Biscoumacetate. Ethyl Chloride. Ethylenediamine Hydrate. Gallamine Triethiodide. Gallamine Injection. Gentian. Gentian Compound Infusion. Ginger. Halothane. Hamamelis. Helium. Heparin. Hexamethonium Tartrate. Histamine Acid Phosphate. Human Blood, whole. Human Red Blood Corpuscles, concentrated. Human Fibrin Foam. Human Fibrinogen. Human Gamma Globulin. Human Gamma Globulin Injection. Human Serum, dried. Human Serum, liquid. Human Plasma, dried. Human Thrombin. Hydrocortisone Acetate. Hydrocortisone Acetate Ointment. Hydrocortisone Hydrogen Succinate. Hydrocortisone Ointment. Hydrogen Peroxide Solution, strong. Hydroxychloroquine Sulphate. Hyoscine Eye Ointment. Hyoscyamus. Iodised Oil Injection. Iodoxyl. Iopanoic Acid. Iopanoic Acid Tablets. Ipecacuanha. Ipecacuanha, prepared. Isoniazid Lead Acetate. |
First Schedule—continued.
Lead Monoxide. Lemon Peel, dried. Lemon Peel, fresh. Leptazol. Lignocaine and Adrenaline Injection. Lignocaine Hydrochloride. Lignocaine Hydrochloride Injection. Liothyronine Sodium. Liothyronine Tablets. Lucanthone Hydrochloride. Male Fern. Maleic Acid. Mannitol. Mepacrine Hydrochloride. Mephenesin. Mephenesin Injection. Mercaptopurine. Mercuric Oxide, yellow. Mercury. Mersalyl Acid. Methadone Hydrochloride. Methoin. Methyltestosterone. Methylamphetamine Hydrochloride. Methylthiouracil. Mustine Hydrochloride. Nalorphine Hydrobromide. Naphazoline Hydrochloride. Neostigmine Bromide. Neostigmine Methylsulphate. Nicotinic Acid. Nikethamide. Nitrous Oxide. Nux Vomica. Oestradiol Benzoate. Opium. Opium, powdered. Orange Peel, dried bitter. Orange Peel, fresh bitter. Ouabain. Oxygen. Oxytetracycline Dihydrate. Paramethadione. Pentamidine Injection. Pentamidine Isethionate. Pethidine Tablets. Phenindamine Tartrate. Phenindione. Pheniodol. Phenolphthalein Tablets. Phenolsulphonphthalein. Phytomenadione. Phytomenadione Capsules. Picrotoxin. Poliomyelitis Vaccine. Potassium Perchlorate. | Prednisone Acetate. Primaquine Phosphate. Primidone. Probenecid. Procyclidine Hydrochloride. Procaine and Adrenaline Injection. Progesterone. Proguanil Hydrochloride. Propyliodone. Propyliodone Injection. Propyliodone Oily Injection. Propyl Thirouracil. Pyridostigmine Bromide. Pyrimethamine. Pyrimethamine Tablets. Quillaia. Senna Leaf. Soda Lime. Sodium Aminosalicylate Tablets. Sodium Antimonylgluconate. Sodium Antimonylgluconate Injection. Sodium Aurothiomalate. Sodium Radio-iodide (131I) Injection. Sodium Radio-iodide (131I) Solution. Sodium Radiophosphate (82P) Injection. Sodium Radiophosphate (82P) Solution. Sodium Stibogluconate. Sodium Stibogluconate Injection. Solapsone. Solapsone Tablets. Stibophen. Sulphadimidine Sodium. Suramin. Suxamethonium Bromide. Suxamethonium Chloride. Suxamethonium Chloride Injection. Testosterone. Tetrachloroethylene. Thiomersal. Thiopentone Sodium. Thiopentone Injection. Thyroid. Thyroxine Sodium. Tolazoline Hydrochloride. Tolbutamide. Trichloroethylene. Tryparsamide. Tuberculin, old. Tuberculin Purified Protein Derivative. Tubocurarine Chloride. Tubocurarine Injection. Typhoid-Paratyphoid A and B and Cholera Vaccine. Typhoid-Paratyphoid A and B and Tetanus Vaccine. Yellow Fever Vaccine. |
SECOND SCHEDULE.
Regulation 10 (3.).
DRUGS AND MEDICINAL PREPARATIONS THAT ARE PHARMACEUTICAL BENEFITS ONLY WHEN PRESCRIBED FOR USE IN A DETERMINED FORM OR IN ALLOWABLE COMPOUNDS.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Dried Aluminium Hydroxide Gel, B.P. | Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
| Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
Aluminium Hydroxide Gel. B.P. ...... | Aluminium Hydroxide Gel. B.P. with Light Magnesia B.P. |
| Aluminium Hydroxide Gel. B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P. |
Aluminium Powder .............. | Aluminium Powder with Zinc Oxide B.P. and Liquid Paraffin B.P. |
Amiphenazole Hydrobromide ........ | — |
Amiphenazole Hydrochloride A.P.F. 1955 | — |
Aneurine Hydrochloride B.P. ........ | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Ascorbic Acid B.P. ............... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Attapulgite .................... | Dihydrostreptomycin Sulphate, Attapulgite, Pectin and Hydrated Alumina Powder |
Bendrofluazide ................. | — |
Benethamine Penicillin ............ | Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P. |
Benzalkonium Chloride ............ | — |
Benzathine Penicillin B.P. .......... | Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P. |
Benzylpenicillin B.P. ............. | Fortified Procaine Penicillin Injection B.P. |
| Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
| Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P. |
Benzylpenicillin Sodium B.P. ........ | Streptomycin Sulphate B.P. with Benzylpenicillin Sodium B.P. |
| Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P. |
Bismuth Subnitrate B.P.C. .......... | Resornicol B.P. with Bismuth Subnitrate B.P.C. Zinc Oxide B.P., Starch B.P., Cade Oil B.P., Wool Fat B.P., Sodium Metabisulphite, Water, Hard Paraffin B.P. and Yellow Soft Paraffin B.P. |
Butabarbital Sodium .............. | — |
Carbromal B.P. ................. | Pentobarbitone Sodium B.P. with Carbromal B.P. |
Chloramphenicol B.P. ............. | Chloramphenicol B.P. with Borate Buffer and Sterile Distilled Water |
| Chloramphenicol B.P. with Propylene Glycol B.P. |
| Chloramphenicol B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Chlorpromazine Hydrochloride B.P. ... | — |
Chlortetracycline Calcium .......... | — |
Chlortetracycline Hydrochloride B.P. ... | Chlortetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Clemizole ..................... | — |
SECOND SCHEDULE—continued.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Cortisone Acetate B.P. ............ |
|
Demethylchlortetracycline Hydrochloride | — |
Dexamethasone Sodium Phosphate .... | — |
Dextrochlorpheniramine Maleate ..... | — |
Dicyclomine Hydrochloride ........ | — |
Dienoestrol B.P. ................ | — |
Diethyl Dithiolisophthalate ......... | — |
Dihydrostreptomycin Sulphate | Dihydrostreptomycin Sulphate, Attapulgite, Pectin and Hydrated Alumina Powder |
Diiodohydroxyquinoline B.P. ....... | — |
Diphtheria and Pertussis Vaccine B.P. | Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Diphtheria Vaccine B.P. ........... | Diptheria and Pertussis Vaccine B.P. |
| Diphtheria, Tetanus and Pertussis Vaccine B.P. |
| Diphtheria and Tetanus Vaccine B.P. |
Diphtheria and Tetanus Vaccine B.P. .. | — |
Ergotamine Tartrate B.P. .......... | Ergotamine Tartrate B.P. with Caffeine B.P. |
| Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. and Diphenhydramine Hydrochloride B.P. |
Erythromycin B.P. ............... | — |
Ethotoin ..................... | — |
Ferrous Aminoacetosulphate ........ | — |
Ferrous Succinate ............... | — |
Glucose Indicator ............... | — |
Griseofulvin ................... | — |
Guanethidine Sodium ............. | — |
Haemophilus Influenza Bacterial Serum | — |
Hamamelis Dry Extract ........... | Hamamelis Dry Extract with Zinc Oxide B.P. and Theobroma Oil B.P. |
Hexocyclium Methyl Sulphate ....... | — |
Hydrated Alumina Powder ......... | Dihydrostreptomycin Sulphate, Attapulgite, Pectin and Hydrated Alumina Powder |
Hydrocortisone B.P. ............. | — |
Hydrocortisone Sodium Succinate .... | — |
Isoprenaline Hydrochloride ......... | — |
Isopropamide Iodide ............. | — |
Levallorphan Tartrate ............. | Levallorphan Tartrate with Pethidine Hydrochloride B.P. |
Lofenalac .................... | — |
Meclozine Hydrochloride B.P.C. ..... | — |
Mercuric Oxide Eye Ointment B.P. .... | — |
Methazolamide ................. | — |
Methscopolamine Bromide ......... | — |
Methyclothiazide ............... | — |
Methylphenobarbitone B.P.C. ....... | — |
Methylprednisolone .............. | — |
Minafen ..................... | — |
Naphazoline Nitrate B.P. .......... | Antazoline Hydrocloride B.P. with Naphazoline Nitrate B.P. |
Neomycin Sulphate B.P., Eye Drops ... | Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base |
| Neomycin Sulphate B.P. with Bacitracin B.P. and Polymyxin B. Sulphate B.P. |
Nicotinamide B.P. ............... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Oestrone ..................... | — |
Oleandomycin ................. | Tetracycline with Oleandomycin |
Oleoresin Capsicum .............. | Bile Salts with Cascara Sagrada B.P., Phenolphthalein B.P. and Oleoresin Capsicum |
SECOND SCHEDULE—continued.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Oxyphencyclimine Hydrochloride .... | — |
Oxyphenonium Bromide .......... | — |
Oxytetracycline Hydrochloride B.P. ... | Oxytetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Papaveretum B.P.C. .............. | Papaveretum B.P.C. with Hyoscine Hydrobromide B.P. |
Pancreatin B.P. ................. | — |
Pectin ....................... | Dihydrostreptomycin Sulphate, Attapulgite, Pectin and Hydrated Alumina Powder |
Pempidine Tartrate .............. | — |
Pentolinium Tartrate B.P. .......... | Pentolinium Tartrate B.P. with Ephedrine B.P. |
Pethidine Hydrochloride B.P. ....... | Pethidine Hydrochloride B.P. with Hyoscine Hydrobromide B.P. |
| Pethidine Hydrochloride B.P. with Levallorphan Tartrate |
Pertussis Vaccine B.P. ............ | Diphtheria, Tetanus and Pertussis Vaccine B.P. |
| Diphtheria and Pertussis Vaccine B.P. |
Phenoxymethylpenicillin B.P. ....... | — |
Phenoxymethylpenicillin (Benzathine Salt) | — |
Phenoxymethylpenicillin Calcium B.P. | — |
Phenoxymethylpenicillin (Hydrabamine Salt) | — |
Phenoxymethylpenicillin Potassium B.P. | — |
Pipenzolate ................... | — |
Polymyxin B. Sulphate B.P. ........ | Polymyxin B. Sulphate B.P. with Mucilage of Methylcellulose and Distilled Water B.P. |
| Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base |
| Polymyxin B. Sulphate B.P. with Ophthalmic Phosphate Buffer |
| Polymyxin B. Sulphate B.P. with Acetic Acid B.P. and Propylene Glycol B.P. |
| Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Bacitracin B.P. |
| Polymyxin B. Sulphate B.P. with Tetracycline Hydrochloride |
Prednisolone B.P. ............... | Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
| Prednisolone B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Prednisolone Disodium Phosphate .... | — |
Prednisone B.P. ................ | Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. |
Procaine Hydrochloride B.P. | Procaine Hydrochloride B.P. in Normal Saline |
| Tetracycline and Procaine Injection B.P. |
Pyrazinamide .................. | — |
Pyrvinium Pamoate .............. | — |
Pyridine Aldoxime Methiodide ...... | — |
Pyrimido-Pyrimidine ............. | — |
Pyrrolidino-Methyl—Tetracycline .... | — |
Rauwolfia Alkaloids ............. | — |
Reserpine B.P. ................. | — |
Riboflavine B.P. ................ | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Sobee ....................... | — |
SECOND SCHEDULE—continued.
Pharmaceutical Benefit. | Allowable Compounds (if any). |
Sodium Chloride B.P. with Potassium Chloride B.P. and Hydrated Calcium Chloride B.P. in Water for Injection B.P. | Sodium Chloride B.P. with Potassium Chloride B.P., Hydrated Calcium Chloride B.P., Water for Injection B.P. and Dextrose B.P. |
Compound Sodium Lactate Injection B.P. | Compound Sodium Lactate Injection B.P. with Dextrose B.P. |
Sodium Lauryl Sulphate B.P. ........ | Emulsifying Wax B.P. |
Streptomycin Sulphate B.P. ......... | Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. |
| Benzylpenicillin Sodium B.P. with Streptomycin Sulphate B.P. |
| Streptomycin Sulphate B.P. with Normal Saline |
Sulphadimidine B.P. ............. | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P. |
Sulphaguanidine B.P. ............. | Sulphaguanidine B.P. and Streptomycin Sulphate B.P. |
Sulphamerazine B.P. ............. | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P. |
| Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole |
| Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide |
Sulphacetamide ................ | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide |
Sulphathiazole ................. | Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole |
Tacrine ...................... | Tacrine with Morphine |
Terpineol B.P. ................. | Solution of Chloroxylenol B.P. |
Tetanus Vaccine B.P. ............. | Diphtheria, Tetanus and Pertussis Vaccine B.P. |
Tetracycline Hydrochloride B.P. ..... | Tetracycline Hydrochloride B.P. with Nystatin |
| Tetracycline and Procaine Injection B.P. |
| Tetracycline Hydrochloride B.P. with a buffering agent |
| Tetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P. |
Tetracycline ................... | Tetracycline with Oleandomycin |
Thenalidine ................... | Thenalidine with Calcium Lactate B.P. and Calcium Gluconate B.P. |
Theobroma Prepared B.P.C. ........ | Calcium Gluconate B.P. with Sucrose B.P., Vanillin B.P. and Theobroma Prepared B.P.C. |
Triamcinolone ................. | — |
Trifluoperazine ................. | — |
Tricyclamol Chloride ............. | — |
Tripelennamine Hydrochloride ...... | — |
Troxidone B.P. ................. | — |
Typhoid Para-Typhoid A and B Vaccine B.P. | Typhoid Para-Typhoid A, B and C Vaccine B.P. |
Tyrothricin ................... | Tyrothricin with a buffering agent |
Concentrated Vitamin A Solution B.P. | Concentrated Vitamins A and D Solution B.P. |
Concentrated Vitamin D Solution B.P. | Concentrated Vitamins A and D Solution B.P. |
Vitamin D .................... | Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D |
Yellow Mercuric Oxide B.P. ........ | Mercuric Oxide Eye Ointment B.P. |
THIRD SCHEDULE.
Regulation 11.
PHARMACEUTICAL BENEFITS ADDITIONAL TO PHARMACEUTICAL BENEFITS IN THE BRITISH PHARMACOPOEIA.
Acetazolamide Sodium. Acetyl-Sulphamethoxypyridazine. Aconite Liniment, B.P.C. Acriflavine, B.P. 1948. Adrenaline Hydrochloride Solution, B.P. 1953. Adrenaline in Oil. Adrenaline Mucate. Agar, B.P.C. Aloes Pill, B.P. 1948. Aloin, B.P. 1953. Aloxidone. Aluminium Acetate Solution, B.P.C. Aluminium Powder. Amaranth Solution A.P.F. Amaranth Solution B.P.C. 1954. Amidopyrin, B.P.C. 1954. Amiphenazole Hydrobromide. Amiphenazole Hydrochloride, A.P.F. 1955. Ammonium Acetate, Strong Solution, B.P. 1953. Ammonium Bicarbonate, B.P. 1953. Ammonium Bromide, B.P.C. Amphotericin B. Androstanolone. Aniseed Water, concentrated, B.P.C. Spirit of Aniseed, B.P.C. 1949. Aromatic Ammonia Spirit, B.P. 1953. Attapulgite. Aurothioglucose. Balsam of Peru, B.P.C. Beeswax, Yellow, B.P.C. Belladonna Suppository, B.P. 1948. Bendrofluazide. Benzalkonium Chloride. Benzoinated Lard, B.P.C. 1954. Bephenium Hydroxynaphthoate. Betamethasone. Bismuth Carbonate, B.P. 1953. Bismuth Glycollylarsanilate. Bismuth Subgallate, B.P. 1953. Bismuth Subnitrate, B.P.C. Borate Buffer. Bretylium Tosylate. Brown Snake Antivenene. Buchu Concentrated Infusion, B.P.C. 1954. Butabarbital Sodium. Butyl Aminobenzoate, B.P. 1953. Caffeine Citrate, B.P.C. Spirit of Cajuput, B.P. 1948. Calamine Cream, A.P.F. Calcium Aurothiomalate. Calcium Di-Oxytetracycline. Calcium. Aminosalicylate, B.P.C. Calcium Phosphate, B.P. 1953. Calumba Concentrated Infusion, B.P. 1948. Calumba Tincture, B.P. 1948. Camphor Water, concentrated, B.P.C. 1949. | Capsicum Ointment, B.P.C. Capsicum Tincture, B.P.C. Caramiphen Hydrochloride. Oil of Caraway, B.P.C. Cardamom Aromatic Tincture, B.P.C. Carmine Solution, A.P.F. Catechu Tincture, B.P.C. Cetyl Alcohol Compound. Charcoal. Chiniofon, B.P. 1948. Chlorambucil. Chlorazanil. Chlormerodrin. Chlorobenzol Disulphonamide. Chloroform Water, concentrated, B.P.C. Chlorpheniramine Maleate. Chlorpropamide. Chlortetracycline Calcium. Chlorthalidone. Spirit of Cinnamon, B.P.C. 1949. Clemizole Hydrochloride. Cloves, Concentrated Infusion, B.P.C. 1954. Tincture of Cochineal, B.P. 1948. Coconut Oil, B.P.C. 1949. Codeine, B.P.C. 1954. Cod Liver Oil Emulsion, B.P., 1953. Colchicine Salicylate. Colocynth and Hyoscyamus Pill, B.P.C. Colocynth, B.P.C. Colocynth Compound Powder Extract, B.P.C. Compound Effervescent Powder, B.P. 1953. Creosote, B.P. 1953. Crude Coal Tar. Tincture of Cudbear, A.P.F. 1947. Cyclophosphamide. Cycloserine. Cycrimine Hydrochloride. Cymogran. Cyproheptadine. D-Cycloserine. Darrow’s Solution. Demecarium Bromide. Demethylchlortetracycline Hydrochloride. Desacetyl-Lanatoside, C. Dexamethasone Dexamethasone odium Phosphate. Dextran Iron. Dextrin Iron. Dextrochlorpheniramine Maleate. Dichlorphenamide. Dicyclomine Hydrochloride. Diethazine Hydrochloride. Diethyl Dithiolisophthalate. Diloxanide Furoate. Digitoxin, B.P.C. Dihydroergotamine. Dihydromorphinone Hydrochloride, B.P.C. 1949. |
THIRD SCHEDULE—continued.
Diphenylpyraline Hydrochloride. Diphenylthiourea. Diphtheria Toxoid Purified. Disodium Diethylstilboestrol Diphosphate. Disodium Dihydrogen Versenate. Dithiazanine Iodide. Ephedrine Sulphate, B.P.C. 1954. Ergot Liquid Extract, B.P.C. 1954. Erythrityltetranitrate, B.P.C. 1949. Erythromycin Glucoheptonate. Erythromycin Propionate. Erythromycin Stearate. Ethotoin. Ethoxzolamide. Ethylidene Dicoumarin. Ethylnoradrenaline. Ferric Hydroxide. Ferric Chloride Solution, B.P.C. Ferrous Aminoacetosulphate. Ferrous Phosphate Compound Syrup, B.P.C. Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C. Ferrous Succinate. Fludrocortisone Acetate. Fluoxymesterone. Formyl-Tetrahydropteroyl Glutamic Acid. Fructose, B.P. 1948. Gall with Opium Ointment, B.P.C. Gelsemium Tincture, B.P.C. Gentian Violet. Glucose Indicator. Glucose Liquid, B.P. 1953. Glutethimide, B.P.C. Glycerophosphates Compound Syrup, A.P.F. Griseofulvin. Guanethidine Sodium. Guanethidine Sulphate. Haemophilus Influenza Bacterial Serum. Hamamelis Dry Extract. Heparin Retard. Hexachlorophene, 3% with Entsufon. Hexachlorophene, 3% with Lissapol. Hexachlorophene, 1.5% with Soap Solution. Hexachlorothiazide. Hexocyclium Methyl Sulphate. Hexoestrol. Honey, Purified, B.P.C. Hydrated Alumina Powder. Hydrocalciferol. Hydrocyanic Acid Dilute, B.P.C. 1954. Hydroflumethiazide. Hypophosphorous Acid Dilute, B.P.C. Insulin Isophone (N.P.H.). Insulin Special P (Pig). Iodochlorhydroxyquinoline. Iodoform B.P.C. Iodoform Suppository, B.P. 1948. Ipomoea Resin. Iron Carbonate Saccharated, B.P.C. Iron Oxide Saccharated. Iron Carbohydrate Complex. Isoprenaline Hydrochloride. | Isopropamide Iodide. Oil of Spike Lavender, B.P.C. Syrup of Lemon, neutral, A.P.F. Levallorphan Tartrate. Levorphanol Tartrate, B.P.C. Lobelia Ethereal Tincture, B.P.C. Lofenalac. Magenta, B.P.C. Magnesium Bicarbonate Solution, B.P. 1948. Mecamylamine. Mecholyl Chloride. Meclozine Hydrochloride, B.P.C. Mephentermine Sulphate. Mercaptomerin Sodium. Mercuric Chloride, B.P. 1953. Mercurous Chloride Ointment, B.P. 1948 Mercury Compound Ointment, B.P.C. Methazolamide. Methenamine Mandelate. Methicillin. Methotrexate. Methscopolamine Bromide. Methyclothiazide. Methyl Androstanolone. Methyl Atropine Nitrate. Methylcellulose A.P.F. Methylcellulose Mucilage, A.P.F. Methyl Prednisolone. Methylandrostenediol. Methylphenobarbitone, B.P.C. Minafen. Myrrh, B.P.C. Myrrh Tincture, B.P.C. Nandrolone. Nicoumalone. Nitrofurantoin. Nitromin. Nitrous Ether Spirit, B.P.C. Norethandrolone. Nux Vomica Extract, Dried, B.P. 1953. Nystatin. Oestradiol Dipropionate. Oestrone. Oleandomycin. Olcoresin Capsicum. Orange Peel Infusion Concentrated, B.P. 1948. Orange Peel Infusion Concentrated, Compound, B.P.C. Ox-Bile Extract, B.P. 1948. Oxymel, B.P.C. Oxymel of Squill, B.P.C. Oxyphencyclimine Hydrochloride. Oxyphenonium Bromide. Pancrex 5. Para-Aminosalicylic Acid. Paraben Ophthalmic Phosphate Buffer, A.P.F. Paraben Ophthalmic Vehicle, A.P.F. Papaveretum, B.P.C. Pectin. Pempidine Tartrate. Benzylpenicillin in Oil. Penicillin Benethamine. |
THIRD SCHEDULE—continued.
Penicillinase. Pentaerythritol Tetranitrate. Penthienate. Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed). Phenazone, B.P.C. Phenethicillin. Phenformin. Phenoxymethylpenicillin (Benzathine Salt). Phenoxymethylpenicillin (Hydrabamine Salt). Phensuximide. Phenylbutazone. Phenylmercuric Dinaphthylmethane Disulphonate. Phthalylsulphacetamide. Pholcodine, B.P.C. Pholcodine Citrate Syrup, B.P.C. Physostigmine Alkaloid. Pipenzolate. Pituitary (Posterior Lobe). Potash Sulphurated, B.P.C. Potassium Chlorate, B.P.C. Prednisolone Disodium Phosphate. Prednisolone Sodium Hemisuccinate. Prophenpyridamine Para-Aminosalicylate. Protamine Sulphate. Protoveratrines A. Pyrazinamide. Pyridine Aldoxime Methiodide. Pyridoxine Hydrochloride, B.P.C. Pyrimido-Pyrimidine. Pyrrolidino-Methyl-Tetracycline. Pyrvinium Pamoate. Quassia Tincture, B.P. 1948. Tincture of Quillaia, B.P.C. Rauwolfia Alkaloids. Ristocetin. Salicylazosulphapyridine. Senega Concentrated Infusion, B.P.C. Senna Compound Mixture, B.P.C. Senna Leaf Concentrated Infusion, B.P.C. Siberian Fir Oil, B.P.C. 1949. Silver Picrate, B.P.C. 1949. Silver Protein Mild, B.P.C. Soap Curd, B.P.C. Soap Hard, B.P.C. Sobee. Sodium Calcium Edetate. Sodium Carbonate Exsiccated, B.P.C. Sodium Folate. Sodium Lactate. Sodium Nitrite, B.P.C. Sodium Oleate Acid. Sodium Tauroglycocholate. | Sorbolene, A.P.F. Spiramycin. Spironolactone. Syrup of Squill, B.P.C. Squill Tincture. Squill Vinegar, B.P. 1948. Stearic Acid, B.P.C. Strophanthus Tincture, B.P. 1948. Strychnine, B.P.C. Sulfinpyrazone. Sulphacetamide. Sulphadiazine Sodium. Sulphadimethoxine. Sulphamethoxypyridazine. Sulphafurazole. Sulphamethizole. Sulphaphenazole. Sulphathiazole. Sulphapyridine, B.P.C. Sulphuric Acid Dilute, B.P.C. Sustanon. Syntocinon. Syrup, Red. Tacrine. Talc Purified, B.P.C. Testosterone Oenanthate. Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed. Tetracycline. Thenalidine. Theobromine, B.P.C. Theobroma Prepared, B.P.C. Thiacetazone. Thiambutosine. Thiouracil, B.P. 1948. Thyrotropin. Tiger Snake Antivenene. Tretamine. Triamcinolone. Tricyclamol Chloride. Triethanolamine, B.P.C. Triethanolamine Trinitrate. Triethylene Thiophosphoramide. Trifluoperazine. Trimetaphan Camphorsulphonate. Trinitrophenol, B.P.C. Triprolidine Hydrochloride. Tyrothrycin. Valerian Ammoniated Tincture, B.P.C. Vasopressin Tannate in Oil. Veriloid. Vitamin A. Vitamin D. Vitamin K. Volatile Bitter Almond Oil, B.P. 1953. Warfarin Sodium. |
FOURTH SCHEDULE.
Regulation 12.
ADDITIVES.
Acetone, B.P.C. Alcohol, B.P. Amethocaine Hydrochloride, B.P. Bacitracin, B.P. Carmine Solution, A.P.F. | Cod Liver Oil, B.P. Oil of Caraway, B.P.C. Oil of Citronella, B.P.C. Xylene, B.P.C. 1949. |
FIFTH SCHEDULE
Regulation 14.
PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Amiphenazole Hydrobromide | As an antidote to barbiturate and other hypnotic poisons |
Amiphenazole Hydrochloride A.P.F. 1955 | |
Amphotericin B ................ | Systemic fungal infections |
Androstanolone ................ | Mammary carcinoma |
Aneurine Hydrochloride Tablets B.P. .. | Any disease or condition in a pensioner |
Ascorbic Acid Tablets B.P. ......... | Any disease or condition in a pensioner |
Bemegride Injection B.P. .......... | As an antidote to barbiturate and other hypnotic poisons |
Betamethasone ................. | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Busulphan Tablets B.P. ........... | The leukaemias
|
Calciferol Tablets B.P. ............ | Any disease or condition in a pensioner |
Calciferol Solution B.P. ........... | Any disease or condition in a child under the age of twelve years or in a pensioner |
Calcium Para-Aminosalicylate B.P.C. | Tuberculosis |
Caramiphen Hydrochloride ......... | Parkinsonism |
Chlorambucil .................. | Malignant lymphoma and related conditions |
Chloramphenicol Capsules B.P. ...... | Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate |
| Bacterium coli meningitis, if other forms of treatment are unsuccessful |
| Brucellosis |
| Granuloma inguinale |
| Friedlander bacillus infections |
| Haemophilus influenzae infections |
| Laryngo-tracheo-bronchitis, acute |
| Lymphogranuloma venereum |
| Pre-operative prophylaxis |
| Salmonella infections |
| Staphylococcal infections |
| Surgical conditions of the bowel (pre-operative and post-operative) |
| Typhoid fever |
| Typhus and other rickettsial diseases |
| Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides |
| Whooping cough (Haemophilus pertussis) |
| As an alternative to the Penicillins in a person sensitive to the Penicillins |
| Severe gastro-enteritis in a child under the age of sixteen years |
Chloramphenicol B.P., Injection ...... | A disease or condition specified in this column in relation to Chloramphenicol Capsules |
Chloramphenicol B.P., Oral Suspension | A disease or condition, specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Chlorpromazine Hydrochloride B.P. ..... | Any disease or condition in a pensioner |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
Chlortetracycline Capsules B.P. ........ | As an alternative to the Penicillins in a person sensitive to the Penicillins |
| Actinomycosis |
| Amoebiasis |
| Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute |
| Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate |
| Bronchiectasis |
| Brucellosis |
| Chancroid |
| Fibrocystic disease of the pancreas |
| Granuloma inguinale |
| Friedlander bacillus infections |
| Leptospirosis |
| Lymphogranuloma venereum |
| Mucoviscidosis |
| Pneumonia that is resistant both to the Penicillins and the Sulphonamides |
| Pre-operative prophylaxis |
| Primary atypical pneumonia |
| Psittacosis |
| Puerperal infections |
| Rat-bite fever (Spirillum minus) |
| Staphylococcal infections |
| Trachoma that is resistant to the Sulphonamides |
| Typhus and other rickettsial diseases |
| Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides |
| Whooping cough (Haemophilus pertussis) |
Chlortetracycline Calcium ......... | A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years |
Chlortetracycline B.P. Granules | |
Cod Liver Oil, B.P. | Any disease or condition in a child under the age of twelve years or in a pensioner |
Cod Liver Oil Emulsion B.P. 1953 | |
Corticotrophin Injection B.P. Corticotrophin Gelatin Injection B.P. Corticotrophin Zinc Hydroxide Injection B.P. | With the written authority of the Director-General— |
A disease or condition specified in this column in relation to Cortisone Injection | |
The treatment of side effects of corticosteroid therapy | |
Cortisone Injection B.P. ........... | With the written authority of the Director-General— |
| Anaemia, acquired haemolytic |
| Addison’s disease and other forms of adrenocortical hypoplasia |
| Adrenalectomy, total |
| Adrenogenital syndrome |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
| Cranial arteritis |
| Cushing’s syndrome, including hyperadrenocorticalism |
| Dermatitis, acute exfoliative, associated with drug therapy |
| Dermatomyositis |
| Encephalomyelitis |
| Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy |
| Hansen’s disease |
| Hepatitis, progressive or continuing, proven by biopsy or biochemistry |
| Keratoplasty |
| The leukaemias |
| Metastatic breast carcinoma |
| Nephritis, type II. |
| Nephrotic syndrome |
| Neuro-myelitis optica |
| Optic neuritis following removal of tumor of the brain |
| Panhypopituitarism |
| Pemphigus |
| Periarteritis nodosa |
| Pseudohermaphroditism |
| Purpura, Henoch’s |
| Purpura, thrombocytopenic |
| Rheumatic carditis, acute |
| Salaam convulsions and hypsarrythmia |
| Sarcoidosis |
| Scleroderma |
| Splenic neutropenia and agranulocytosis |
| Status asthmaticus |
| Steroid therapy prior to operation in patients under steroid therapy |
| Stevens-Johnson syndrome |
| Still’s disease in a child under the age of sixteen years |
| Sympathetic ophthalmitis |
| Systemic lupus erythematosus |
| Temporal arteritis |
| Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases |
| Ulcerative colitis proven by sigmoidoscopy or radiological report |
| Uveitis, posterior |
Cortisone Tablets B.P. ............ | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Cyanocobalamin Injection B.P. (other than 1,000 microgramme strength) | Established megalocytic anaemias |
Cyanocobalamin Injection B.P., 1,000 microgramme strength | Neuroblastoma |
Cymogran .................... | With the written authority of the Director-General, phenylketonuria |
Cycloserine ................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
D-Cycloserine ................. | |
Demethylchlortetracycline Hydrochloride | A disease or condition specified in this column in relation to Chlortetracycline Capsules |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Deoxycortone Acetate B.P. ........... | Addison’s disease Total adrenalectomy |
Deoxycortone Acetate Injection B.P. | |
Deoxycortone Acetate Implant B.P. | |
Dexamethasone ................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Dexamethasone Sodium Phosphate | |
Dextrochlorpheniramine Maleate Syrup | Any disease or condition in a child under the age of twelve years |
Dienoestrol B.P., Cream ............. | Any disease or condition in a pensioner |
Dienoestrol Tablets B.P. ............. | Carcinoma of the prostate |
| Mammary carcinoma |
| Any disease or condition in a pensioner |
Diethyl Dithiolisophthalate ........... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Diiodohydroxyquinoline B.P., Vaginal Tablet | Trichomonal and monilial vaginitis |
Dihydrostreptomycin Sulphate Injection B.P. | An as alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate |
Diloxanide Furoate ................ | Amoebic dysentery |
Disodium Diethylstilboestrol Diphosphate | Carconoma of the prostate |
Erythromycin B.P. ................. | Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins |
Erythromycin Tablets B.P. ........... | |
Erythromycin Glucoheptonate | |
Erythromycin Propionate | |
Erythromycin B.P., Oral Sachet | Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins in a child under the age of twelve years |
Erythromycin B.P., Oral Suspension | |
Erythromycin Stearate, Oral Suspension | |
Ethinyloestradiol Tablets B.P. ......... | Turner’s syndrome |
| Pre-menopausal castration syndrome |
| Any disease or condition in a pensioner |
Ethisterone Tablets B.P. ............. | Turner’s syndrome |
| Habitual abortion |
| Any disease or condition in a pensioner |
Ferric Hydroxide ................ | Any disease or condition in a child under the age of twelve years |
Ferrous Aminoacetosulphate Syrup | |
Ferrous Gluconate Elixir ........... | |
Ferrous Succinate Syrup ............ | |
Fludrocortisone Acetate ............. | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Fluoxymesterone .................. | Mammary carcinoma |
Folic Acid B.P. ................. | Macrocytic anaemia |
Folic Acid Tablets B.P. ............ | Sprue or the sprue-like syndrome |
Formyl-Tetrahydropteroyl Glutamic Acid | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Griseofulvin ..................... | With the written authority of the Director-General— |
| For the treatment of any of the following diseases, the diagnosis of which has been confirmed by pathological report:— |
| Epidermophyton floccosum |
| Microsporum audouni |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
| Microsporum canis |
| Microsporum gypseum |
| Trichophyton interdigitale |
| Trichophyton mentagrophytes |
| Trichophyton rubram |
| Trichophyton schoenleini |
| Trichophyton sulphureum |
| Trichophyton verrucosum |
Haemophilus Influenza Bacterial Serum | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Hexachlorophene, 3% with Entsufon | |
Hexachlorophene, 3% with Lissapol | |
Hexachlorophene, 1.5% with Soap Solution | |
Hydrocalciferol ................. | Parathyroid deficiency |
Hydrocortisone Injection B.P. ....... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Hydrocortisone Sodium Succinate B.P. | With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report |
Hydrocortisone Sodium Succinate Injection B.P. | Acute adrenal failure due to a medical or surgical crisis |
| Stevens-Johnson syndrome |
Iron Oxide Saccharated ........... | As an alternative to Oral Iron in a person unable to take Oral Iron |
Isoniazid Tablets B.P. ............ | Hansen’s disease |
| Tuberculosis |
Levorphanol Tartrate B.P.C. ........ | Inoperable cancer |
Lofenalac .................... | With the written authority of the Director-General, phenylketonuria |
Malt Extract B.P. ............... | Any disease or condition in a child under the age of twelve years or in a pensioner |
Malt Extract with Cod Liver Oil B.P. | |
Mercaptopurine Tablets B.P. ........ | Allergic angiitis |
| Periarteritis |
| Systemic lupus erythematosus |
| The leukaemias |
Methicillin .................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Methyl Androstanolone ........... | Mammary carcinoma |
Methylandrostenediol ............ | Senile osteoporosis proven by radiography |
Minafen ..................... | With the written authority of the Director-General, phenylketonuria |
Mustine Injection B.P. ............ | Malignant lymphoma and related conditions |
Nandrolone Phenpropionate ........ | Mammary carcinoma |
Neomycin Sulphate B.P., in a form other than Eye Drops | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Nicotinamide Tablets B.P. ......... | Any disease or condition in a pensioner |
Nicotinic Acid Tablets B.P. ......... | Any disease or condition in a pensioner |
Nitrofurantoin ................. | Urinary tract infections |
Nitrofurantoin Suspension ......... | Any urinary tract infection in a child under the age of twelve years |
Nitromin ..................... | Malignant lymphoma and related conditions |
Norethandrolone ................ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Novobiocin Calcium B.P. ......... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Novobiocin Sodium B.P. ......... | |
Novobiocin Tablets B.P. .......... | |
Nystatin ..................... | Proven monilia infections |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Oxytetracycline Tablets B.P. | A disease or condition specified in this column in relation to Chlortetracycline Capsules |
Oxytetracycline Injection B.P. | |
Oxytetracycline and Procaine Injection B.P. | |
Calcium Di-Oxytetracycline ........ | A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years |
Oxytetracycline Paediatric Drops | |
Pancreatin B.P. ................. | Fibrous disease of the pancreas |
| Pancreatico-duodenectomy |
Pancrex 5 .................... | Fibrous disease of the pancreas |
| Pancreatico-duodenectomy |
Para-Aminosalicylic Acid .......... | Tuberculosis |
Pethidine and Levallorphan Tartrate ... | Obstetrical use |
Phenoxymethylpenicillin B.P., Oral Suspension} |
|
Phenoxymethylpenicillin (Benzathine Salt), Oral Suspension |
|
Phenoxymethylpenicillin Calcium B.P., Oral Suspension | Any disease or condition in a child under the age of twelve years |
Phenoxymethylpenicillin (Hydrabamine Salt), Oral Suspension |
|
Phenoxymethylpenicillin. Potassium B.P., Oral Suspension |
|
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P. | Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
Phytomenadione Injection B.P. ...... | Antidote to anticoagulants |
Piperazine Citrate B.P., Elixir ....... | Any disease or condition in a child under the age of twelve years |
Prednisolone Disodium Phosphate .... | With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report |
Prednisolone Tablets B.P. .......... | With the written authority of the Director-General— |
| Anaemia, acquired haemolytic |
| Adrenogenital syndrome |
| Cranial arteritis |
| Cushing’s syndrome, including hyperadrenocorticalism |
| Dermatitis, acute exfoliative, associated with drug therapy |
| Dermatomyositis |
| Encephalomyelitis |
| Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis proven by lung biopsy |
| Hansen’s disease |
| Hepatitis, progressive or continuing, proven by biopsy or biochemistry |
| The leukaemias |
| Nephritis, typo II. |
| Nephrotic syndrome |
| Neuro-myelitis optica |
| Optic neuritis following removal of tumour of the brain |
| Panhypopituitarism |
| Pemphigus |
| Periarteritis nodosa |
| Pseudohermaphroditism |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
| Purpura, Henoch’s |
| Purpura, thrombocytopenic |
| Rheumatic carditis, acute |
| Salaam convulsions and hypsarrythmia |
| Sarcoidosis |
| Scleroderma |
| Splenic neutropena and agranulocytosis |
| Status asthmaticus |
| Steroid therapy prior to operation in patients under steriod therapy |
| Still’s disease in a child under the age of sixteen years |
| Sympathetic ophthalmitis |
| Systemic lupus erythematosus |
| Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases |
| Ulcerative colitis proven by sigmoidoscopy or radiological report |
| Uveitis, posterior |
Methyl Prednisolone ............. | With the written authority of the Director-General, a disease or condition specified in this column in relation to Prednisolone Tablets |
Prednisolone Acetate B.P. .......... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P. | |
Prednisolone Sodium Hemisuccinate | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Prednisone Tablets B.P. ........... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium | |
Hydroxide Gel. B.P. ............. | |
Progesterone Injection B.P. ......... | Habitual abortion |
Protoveratrines A ............... | Hypertensive crisis |
Pyrazinamide .................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Pyridine Aldoxime Methiodide ...... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Pyridostigmine Injection B.P. ....... | Myasthenia gravis |
Pyridostigmine Tablets B.P. ........ | Myasthenia gravis |
Riboflavine Tablets B.P. ........... | Any disease or condition in a pensioner |
Ristocetin .................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Salicylazosulphapyridine .......... | Ulcerative colitis |
Sobee ....................... | With the written authority of the Director-General, galactosaemia |
Sodium Aminosalicylate B.P. | Tuberculosis |
Sodium Aminosalicylate Tablets B.P. | |
Sodium Folate ................. | Macrocytic anaemia |
Sprue or the sprue-like syndrome | |
Spironolactone................. | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Stilboestrol B.P. ............... | Carcinoma of the prostate |
Stilboestrol Tablets B.P........... | Mammary carcinoma |
Any disease or condition in a pensioner |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Streptomycin Sulphate B.P. .......... | Bacillary dysentery that is resistant to the Sulphonamides |
| Brucellosis |
| Chancroid |
| Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
| Friedlander bacillus infections |
| Haemophilus influenzae infections |
| Plague |
| Pseudomonas pyocyaneus infections |
| Rat-bite fever (Streptobacillus moniliformis) |
| Salmonella infections |
| Surgical conditions of the bowel (pre-operative and post-operative) |
| Surgical conditions of the thoracic organs |
| Tuberculosis |
| Tularaemia |
| Urinary tract infections that are resistant to the Sulphonamides |
Streptomycin Sulphate Injection B.P. ... | A disease or condition specified in this column in relation to Streptomycin Sulphate |
Streptomycin Sulphate B.P. with Benzylpenicillin Sodium, B.P. | Endocarditis due to Streptococcus faecalis or Streptococcus viridans |
Sulphadimethoxine Suspension | Any disease or condition in a child under the age of twelve years |
Sulphaphenazole Syrup .......... | |
Sustanon ..................... |
|
Testosterone Implants B.P. ......... | Castration syndrome |
Testosterone Oenanthate ........... | Mammary carcinoma |
Testosterone Propionate Injection B.P. | Castration syndrome |
Testosterone Propionate B.P. | Kline felter Reifenstein Albright syndrome |
Methyltestosterone Tablets B.P. | Mammary carcinoma |
Tetracycline with a buffering agent and Amphotericin B | A disease or condition specified in this column in relation to Tetracycline with Nystatin in a child under the age of twelve years |
Tetracycline Capsules B.P. ........ | A disease or condition specified in this column in relation to Chlortetracycline Capsules |
Tetracycline Tablets B.P. ......... | |
Tetracycline and Procaine Injection B.P. | |
Tetracycline Hydrochloride B.P. with a buffering agent—Capsules | |
Tetracycline Injection B.P. ........ | |
Tetracycline with Oleandomycin Capsules | |
Pyrrolidino-Methyl-Tetracycline | |
Tetracycline with a buffering agent—Oral Suspension} | A disease or condition, specified in this column in relation to Chloretracycline Capsules, in a child under the age of twelve years |
Tetracycline with a buffering agent—Paediatric Drops | |
Tetracycline with Oleandomycin—Oral Suspension | |
Tetracycline with Oleandomycin—Paediatric Drops | |
Tetracycline with Nystatin ........... | Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis |
| A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules |
FIFTH SCHEDULE—continued.
Pharmaceutical Benefit. | Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act. |
Thyrotropin ...................... | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Triamcinolone .................... | With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection |
Triethylene Thiosphosphoramide ........ | Any disease or condition in a patient receiving treatment in or at an approved hospital |
Tretamine ....................... | Malignant lymphoma and related conditions |
Trifluoperazine .................... | Any disease or condition in a pensioner |
| Any disease or condition in a patient receiving treatment in or at an approved hospital |
| With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital |
Trimetaphan Camphorsulphonate ........ | Hypotensive for anaesthesia |
Triprolidine Hydrochloride, Elixir ....... | Any disease or condition in a child under the age of twelve years |
Veriloid ........................ | Hypertensive crisis |
Vitamin A Activity with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D | Any disease or condition in a pensioner |
Concentrated Vitamin A Solution B.P. | Any disease or condition in a child under the age of twelve years or in a pensioner |
Concentrated Vitamin A and D Solution B.P. | |
Concentrated Vitamin D Solution | |
Vitamin K ....................... | As an antidote to anticoagulants |
By Authority: A. J. ARTHUR, Commonwealth Government Printer, Canberra.